Young boys who ate a greater proportion of ultraprocessed foods were more likely to develop overweight or obesity by age 5 years, according to findings published in JAMA Network Open.“Ultraprocessed ...

More than half of adults with overweight or obesity prescribed a GLP-1 discontinue their drug within 1 year, with discontinuation rates higher for those without type 2 diabetes, researchers reported ...

Researchers at the University of Toronto are sounding the alarm about the high consumption of ultra-processed foods among preschool-aged children in Canada and its association with obesity development ...

Among over 125,000 patients, 53.6% discontinued their GLP-1 receptor agonist by 1 year, and these rates were significantly ...

Enobosarm demonstrated a statistically significant benefit in preserving lean mass in patients with overweight or obesity undergoing treatment with semaglutide.Topline results from the Phase ...

(HealthDay News) — For patients with overweight or obesity and type 2 diabetes, dapagliflozin plus regular calorie restriction is associated with a significantly higher rate of remission of diabetes ...

A new study finds that three quarters of American adults and half of adolescents are too heavy. That's making more of us sick and creating enormous health care costs.

Sometimes, the conversation doesn’t get past a handful of words, and just the attempt may threaten the patient-physician ...

Researchers identify a significant association between sugar-sweetened beverage tax and BMI changes among adults living in ...

Imagine being one of the millions of Americans in need of a hip or knee replacement due to osteoarthritis. Severe pain, reduced physical activity, an inability to perform many routine tasks — the ...

If that person loses 20 kilograms (44 pounds) in one year while taking a GLP-1R agonist — which is not unreasonable while ...

While some studies suggest probiotics may help you lose weight and belly fat, more research is needed on their effectiveness.